Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Effect of cell phone radiofrequency radiation on body temperature in rodents: Pilot studies of the National Toxicology Program's reverberation chamber exposure system.

Wyde ME, Horn TL, Capstick MH, Ladbury JM, Koepke G, Wilson PF, Kissling GE, Stout MD, Kuster N, Melnick RL, Gauger J, Bucher JR, McCormick DL.

Bioelectromagnetics. 2018 Apr;39(3):190-199. doi: 10.1002/bem.22116. Epub 2018 Mar 14.

PMID:
29537695
2.

Life-Time Dosimetric Assessment for Mice and Rats Exposed in Reverberation Chambers of the 2-Year NTP Cancer Bioassay Study on Cell Phone Radiation.

Gong Y, Capstick M, Kuehn S, Wilson P, Ladbury J, Koepke G, McCormick DL, Melnick RL, Kuster N.

IEEE Trans Electromagn Compat. 2017 Dec;59(6):1798-1808. doi: 10.1109/TEMC.2017.2665039. Epub 2017 Mar 17.

PMID:
29217849
3.

A Radio Frequency Radiation Exposure System for Rodents based on Reverberation Chambers.

Capstick M, Kuster N, Kuehn S, Berdinas-Torres V, Gong Y, Wilson P, Ladbury J, Koepke G, McCormick DL, Gauger J, Melnick RL.

IEEE Trans Electromagn Compat. 2017 Aug;59(4):1041-1052. doi: 10.1109/TEMC.2017.2649885. Epub 2017 Mar 17.

4.

Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.

Thompson MD, Lubet RA, Mccormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ.

Oncol Lett. 2017 Sep;14(3):3480-3486. doi: 10.3892/ol.2017.6632. Epub 2017 Jul 20.

5.

Complementary roles of gasotransmitters CO and H2S in sleep apnea.

Peng YJ, Zhang X, Gridina A, Chupikova I, McCormick DL, Thomas RJ, Scammell TE, Kim G, Vasavda C, Nanduri J, Kumar GK, Semenza GL, Snyder SH, Prabhakar NR.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):1413-1418. doi: 10.1073/pnas.1620717114. Epub 2017 Jan 23.

6.
7.

5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?

Lubet RA, Townsend R, Clapper ML, Juliana MM, Steele VE, McCormick DL, Grubbs CJ.

Cancer Prev Res (Phila). 2016 Jul;9(7):616-23. doi: 10.1158/1940-6207.CAPR-15-0294. Epub 2016 May 5.

8.

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ.

McCormick DL, Horn TL, Johnson WD, Peng X, Lubet RA, Steele VE.

PLoS One. 2015 Oct 30;10(10):e0141849. doi: 10.1371/journal.pone.0141849. eCollection 2015.

9.

Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humans.

Holleran JL, Beumer JH, McCormick DL, Johnson WD, Newman EM, Doroshow JH, Kummar S, Covey JM, Davis M, Eiseman JL.

Cancer Chemother Pharmacol. 2015 Oct;76(4):803-11. doi: 10.1007/s00280-015-2857-x. Epub 2015 Sep 1.

10.

Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.

Muzzio M, Hu SC, Holleran JL, Parise RA, Eiseman JL, Yellow-Duke AE, Covey JM, Glaze ER, Engelke K, Egorin MJ, McCormick DL, Beumer JH.

Cancer Chemother Pharmacol. 2015 May;75(5):1015-23. doi: 10.1007/s00280-015-2722-y. Epub 2015 Mar 17.

11.

Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide.

Peng X, Li W, Johnson WD, Torres KE, McCormick DL.

PLoS One. 2015 Jan 30;10(1):e0116285. doi: 10.1371/journal.pone.0116285. eCollection 2015.

12.

Characterization of acute biliary hyperplasia in Fisher 344 rats administered the indole-3-carbinol analog, NSC-743380.

Eldridge SR, Covey J, Morris J, Fang B, Horn TL, Elsass KE, Hamre JR 3rd, McCormick DL, Davis MA.

Toxicol Appl Pharmacol. 2014 Dec 15;281(3):303-9. doi: 10.1016/j.taap.2014.10.015. Epub 2014 Oct 28.

13.

Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland.

Mehta RG, Hawthorne M, Mehta RR, Torres KE, Peng X, McCormick DL, Kopelovich L.

PLoS One. 2014 Nov 18;9(11):e113175. doi: 10.1371/journal.pone.0113175. eCollection 2014.

14.

Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21.

Peng X, Li W, Yuan L, Mehta RG, Kopelovich L, McCormick DL.

PLoS One. 2013 Aug 1;8(8):e70442. doi: 10.1371/journal.pone.0070442. Print 2013.

15.

Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.

Lubet RA, Clapper ML, McCormick DL, Pereira MA, Chang WC, Steele VE, Fischer SM, Juliana MM, Grubbs CJ.

Oncol Rep. 2012 May;27(5):1400-6. doi: 10.3892/or.2012.1673. Epub 2012 Feb 3.

PMID:
22307264
16.

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.

Kapetanovic IM, Muzzio M, McCormick DL, Thompson TN, Johnson WD, Horn TL, Mohammed A, Rao CV, Kopelovich L.

Cancer Chemother Pharmacol. 2012 May;69(5):1301-6. doi: 10.1007/s00280-011-1811-9.

PMID:
22302406
17.

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Muzzio M, Huang Z, Hu SC, Johnson WD, McCormick DL, Kapetanovic IM.

J Pharm Biomed Anal. 2012 Feb 5;59:201-8. doi: 10.1016/j.jpba.2011.10.023. Epub 2011 Oct 25.

18.

Systematic review of wireless phone use and brain cancer and other head tumors.

Repacholi MH, Lerchl A, Röösli M, Sienkiewicz Z, Auvinen A, Breckenkamp J, d'Inzeo G, Elliott P, Frei P, Heinrich S, Lagroye I, Lahkola A, McCormick DL, Thomas S, Vecchia P.

Bioelectromagnetics. 2012 Apr;33(3):187-206. doi: 10.1002/bem.20716. Epub 2011 Oct 21. Review.

PMID:
22021071
19.

Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M, McCormick DL.

Food Chem Toxicol. 2011 Dec;49(12):3319-27. doi: 10.1016/j.fct.2011.08.023. Epub 2011 Sep 10.

20.

Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs.

Johnson WD, Muzzio M, Detrisac CJ, Kapetanovic IM, Kopelovich L, McCormick DL.

Toxicology. 2011 Nov 18;289(2-3):141-50. doi: 10.1016/j.tox.2011.08.009. Epub 2011 Aug 16.

21.

Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS.

Muzzio M, Huang Z, Johnson WD, McCormick DL, Kapetanovic IM.

J Pharm Biomed Anal. 2011 Dec 5;56(4):809-14. doi: 10.1016/j.jpba.2011.07.013. Epub 2011 Jul 22.

22.

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL.

Cancer Chemother Pharmacol. 2011 Sep;68(3):593-601. doi: 10.1007/s00280-010-1525-4. Epub 2010 Nov 30.

23.

Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

Kapetanovic IM, Horn TL, Johnson WD, Cwik MJ, Detrisac CJ, McCormick DL.

Int J Toxicol. 2010 Mar-Apr;29(2):157-64. doi: 10.1177/1091581809360070.

PMID:
20335511
24.

Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

McCormick DL, Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Cancer Prev Res (Phila). 2010 Mar;3(3):381-92. doi: 10.1158/1940-6207.CAPR-09-0176. Epub 2010 Feb 9.

25.

Direct quantitation of glucoraphanin in dog and rat plasma by LC-MS/MS.

Cwik MJ, Wu H, Muzzio M, McCormick DL, Kapetanovic I.

J Pharm Biomed Anal. 2010 Aug 1;52(4):544-9. doi: 10.1016/j.jpba.2010.01.020. Epub 2010 Jan 18.

26.

Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.

McCormick DL, Phillips JM, Horn TL, Johnson WD, Steele VE, Lubet RA.

Cancer Prev Res (Phila). 2010 Jan;3(1):73-81. doi: 10.1158/1940-6207.CAPR-09-0151.

27.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys.

Kapetanovic IM, Muzzio M, Hu SC, Crowell JA, Rajewski RA, Haslam JL, Jong L, McCormick DL.

Cancer Chemother Pharmacol. 2010 May;65(6):1109-16. doi: 10.1007/s00280-009-1116-4. Epub 2009 Sep 16.

PMID:
19756605
28.

Antioxidant supplementation and cancer prevention.

Bosland MC, McCormick DL.

JAMA. 2009 May 13;301(18):1877-8; author reply 1878. doi: 10.1001/jama.2009.628. No abstract available.

PMID:
19436010
29.

Efficacy of chemopreventive agents in mouse mammary gland organ culture (MMOC) model: a comprehensive review.

Mehta RG, Naithani R, Huma L, Hawthorne M, Moriarty RM, McCormick DL, Steele VE, Kopelovich L.

Curr Med Chem. 2008;15(27):2785-825. Review.

PMID:
18991637
30.

Antiviral activity of phytochemicals: a comprehensive review.

Naithani R, Huma LC, Holland LE, Shukla D, McCormick DL, Mehta RG, Moriarty RM.

Mini Rev Med Chem. 2008 Oct;8(11):1106-33. Review.

PMID:
18855727
31.

Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials.

Naithani R, Huma LC, Moriarty RM, McCormick DL, Mehta RG.

Curr Med Chem. 2008;15(11):1044-71. Review.

PMID:
18473802
32.

Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist.

Horn TL, Harder JB, Johnson WD, Curry PT, Parchment RE, Morrissey RL, Mellick PW, Calis KA, Gold PW, Rice KC, Contoreggi C, Charney DS, Cizza G, Glaze ER, Tomaszewski JE, McCormick DL.

Toxicology. 2008 Jun 3;248(1):8-17. doi: 10.1016/j.tox.2008.03.002. Epub 2008 Mar 13.

33.

Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.

Johnson WD, Morrissey RL, Kapetanovic I, Crowell JA, McCormick DL.

Food Chem Toxicol. 2008 Mar;46(3):1068-78. Epub 2007 Nov 12.

34.

Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

Horn TL, Torres KE, Naylor JM, Cwik MJ, Detrisac CJ, Kapetanovic IM, Lubet RA, Crowell JA, McCormick DL.

Toxicol Sci. 2007 Oct;99(2):612-27. Epub 2007 Jul 14.

PMID:
17630414
35.

Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat.

McCormick DL, Johnson WD, Haryu TM, Bosland MC, Lubet RA, Steele VE.

Nutr Cancer. 2007;57(2):194-200.

PMID:
17571953
36.

Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.

McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE.

Nutr Cancer. 2007;57(2):184-93.

PMID:
17571952
37.

Community hospital successfully implements eRecord and CPOE.

Wolf DM, Greenhouse PK, Diamond JN, Fera W, McCormick DL.

Comput Inform Nurs. 2006 Nov-Dec;24(6):307-16.

PMID:
17108749
38.

Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

Horn TL, Cwik MJ, Morrissey RL, Kapetanovic I, Crowell JA, Booth TD, McCormick DL.

Food Chem Toxicol. 2007 Jan;45(1):55-63. Epub 2006 Aug 8.

39.

Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.

McCormick DL, Johnson WD, Kozub NM, Rao KV, Lubet RA, Steele VE, Bosland MC.

Carcinogenesis. 2007 Feb;28(2):398-403. Epub 2006 Sep 3.

PMID:
16952912
40.

Oncogenicity evaluations of chemopreventive soy components in p53((+/-)) (p53 knockout) mice.

Johnson WD, Dooley L, Morrissey RL, Arp L, Kapetanovic I, Crowell JA, McCormick DL.

Int J Toxicol. 2006 May-Jun;25(3):219-28.

PMID:
16717037
41.

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.

Glaze ER, Lambert AL, Smith AC, Page JG, Johnson WD, McCormick DL, Brown AP, Levine BS, Covey JM, Egorin MJ, Eiseman JL, Holleran JL, Sausville EA, Tomaszewski JE.

Cancer Chemother Pharmacol. 2005 Dec;56(6):637-47. Epub 2005 Jun 29.

PMID:
15986212
42.

Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.

Horn TL, Long L, Cwik MJ, Morrissey RL, Kapetanovic IM, McCormick DL.

Chem Biol Interact. 2005 Apr 15;152(2-3):79-99.

PMID:
15840382
44.

Reproductive toxicity assessment of chronic dietary exposure to soy isoflavones in male rats.

Faqi AS, Johnson WD, Morrissey RL, McCormick DL.

Reprod Toxicol. 2004 Jun;18(4):605-11.

PMID:
15135855
45.

Childhood leukemia: electric and magnetic fields as possible risk factors.

Brain JD, Kavet R, McCormick DL, Poole C, Silverman LB, Smith TJ, Valberg PA, Van Etten RA, Weaver JC.

Environ Health Perspect. 2003 Jun;111(7):962-70. Review.

46.

Chemoprevention strategies for prostate cancer.

Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S18-27. Review.

PMID:
12570331
47.

Ornithine decarboxylase activity in tissues from rats exposed to 60 Hz magnetic fields, including harmonic and transient field characteristics.

McDonald LJ, Loberg LI, McCormick DL, Gauger JR, Savage RE Jr, Zhu H, Lotz WG, Mandeville R, Owen RD, Cress LW, Desta AB.

Toxicol Mech Methods. 2003;13(1):31-8. doi: 10.1080/15376510309826.

PMID:
20021180
48.

Cell viability and growth in a battery of human breast cancer cell lines exposed to 60 Hz magnetic fields.

Loberg LI, Engdahl WR, Gauger JR, McCormick DL.

Radiat Res. 2000 May;153(5 Pt 2):725-8.

PMID:
10790299
49.
50.

60 Hz magnetic fields do not enhance cell killing by genotoxic chemicals in Ataxia telangiectasia and normal lymphoblastoid cells.

Loberg LI, Luther MJ, Gauger JR, McCormick DL.

Radiat Res. 2000 May;153(5 Pt 2):685-9.

PMID:
10790293

Supplemental Content

Loading ...
Support Center